![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 24, 25497-25502, June 11, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Synuclein Aggregation and Toxicity*




¶
From the
Alzheimer's Disease Research Laboratory, Harvard Medical School, Massachusetts General Hospital, Charlestown, Massachusetts 02129 and the
Department of Neurosciences, University of California San Diego, School of Medicine, La Jolla, California 92093
Aggregation and cytotoxicity of misfolded
-synuclein is postulated to be crucial in the disease process of neurodegenerative disorders such as Parkinson's disease and DLB (dementia with Lewy bodies). In this study, we detected misfolded and aggregated
-synuclein in a Triton X-100 insoluble fraction as well as a high molecular weight product by gel electrophoresis of temporal neocortex from DLB patients but not from controls. We also found similar Triton X-100 insoluble forms of
-synuclein in an
-synuclein transgenic mouse model and in an in vitro model of
-synuclein aggregation. Introducing the molecular chaperone Hsp70 into the in vivo model by breeding
-synuclein transgenic mice with Hsp70-overexpressing mice led to a significant reduction in both the high molecular weight and detergent-insoluble
-synuclein species. Concomitantly, we found that Hsp70 overexpression in vitro similarly reduced detergent-insoluble
-synuclein species and protected cells from
-synuclein-induced cellular toxicity. Taken together, these data demonstrate that the molecular chaperone Hsp70 can reduce the amount of misfolded, aggregated
-synuclein species in vivo and in vitro and protect it from
-synuclein-dependent toxicity.
Received for publication, January 9, 2004 , and in revised form, March 24, 2004.
* This work was supported by the National Institutes of Health Grants NS38372 and AG18440, Deutsche Forschungsgemeinschaft KL 1395/2-1, the Harvard Brain Tissue Resource Center Grant 1R24MH68855, the National Institutes of Health Grant AG05134-20 (to the Massachusetts Alzheimer's Disease Research Center), and National Institutes of Health Grant NS38372A-06 (to the Massachusetts General Hospital-Massachusetts Institutes of Technology Udall Center Brain Bank). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed. Tel.: 617-726-1263; Fax: 617-724-1480; E-mail: pmclean{at}partners.org.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. E. Tetzlaff, P. Putcha, T. F. Outeiro, A. Ivanov, O. Berezovska, B. T. Hyman, and P. J. McLean CHIP Targets Toxic {alpha}-Synuclein Oligomers for Degradation J. Biol. Chem., June 27, 2008; 283(26): 17962 - 17968. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, C. Xie, E. Greggio, L. Parisiadou, H. Shim, L. Sun, J. Chandran, X. Lin, C. Lai, W.-J. Yang, et al. The Chaperone Activity of Heat Shock Protein 90 Is Critical for Maintaining the Stability of Leucine-Rich Repeat Kinase 2 J. Neurosci., March 26, 2008; 28(13): 3384 - 3391. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F. Outeiro, E. Kontopoulos, S. M. Altmann, I. Kufareva, K. E. Strathearn, A. M. Amore, C. B. Volk, M. M. Maxwell, J.-C. Rochet, P. J. McLean, et al. Sirtuin 2 Inhibitors Rescue {alpha}-Synuclein-Mediated Toxicity in Models of Parkinson's Disease Science, July 27, 2007; 317(5837): 516 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Scherzer, A. C. Eklund, L. J. Morse, Z. Liao, J. J. Locascio, D. Fefer, M. A. Schwarzschild, M. G. Schlossmacher, M. A. Hauser, J. M. Vance, et al. Molecular markers of early Parkinson's disease based on gene expression in blood PNAS, January 16, 2007; 104(3): 955 - 960. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Evans, S. Wisen, and J. E. Gestwicki Heat Shock Proteins 70 and 90 Inhibit Early Stages of Amyloid beta-(1-42) Aggregation in Vitro J. Biol. Chem., November 3, 2006; 281(44): 33182 - 33191. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Klucken, T. F. Outeiro, P. Nguyen, P. J. McLean, and B. T. Hyman Detection of novel intracellular {alpha}-synuclein oligomeric species by fluorescence lifetime imaging FASEB J, October 1, 2006; 20(12): 2050 - 2057. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Bodner, T. F. Outeiro, S. Altmann, M. M. Maxwell, S. H. Cho, B. T. Hyman, P. J. McLean, A. B. Young, D. E. Housman, and A. G. Kazantsev From the Cover: Pharmacological promotion of inclusion formation: A therapeutic approach for Huntington's and Parkinson's diseases. PNAS, March 14, 2006; 103(11): 4246 - 4251. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ryo, T. Togo, T. Nakai, A. Hirai, M. Nishi, A. Yamaguchi, K. Suzuki, Y. Hirayasu, H. Kobayashi, K. Perrem, et al. Prolyl-isomerase Pin1 Accumulates in Lewy Bodies of Parkinson Disease and Facilitates Formation of {alpha}-Synuclein Inclusions J. Biol. Chem., February 17, 2006; 281(7): 4117 - 4125. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhou and C. R. Freed DJ-1 Up-regulates Glutathione Synthesis during Oxidative Stress and Inhibits A53T {alpha}-Synuclein Toxicity J. Biol. Chem., December 30, 2005; 280(52): 43150 - 43158. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Shen, J.-C. He, Y. Wang, Q.-Y. Huang, and J.-F. Chen Geldanamycin Induces Heat Shock Protein 70 and Protects against MPTP-induced Dopaminergic Neurotoxicity in Mice J. Biol. Chem., December 2, 2005; 280(48): 39962 - 39969. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Macario and E. C. de Macario Sick Chaperones, Cellular Stress, and Disease N. Engl. J. Med., October 6, 2005; 353(14): 1489 - 1501. [Full Text] [PDF] |
||||
![]() |
A. M. Celotto and M. J. Palladino Drosophila: A "Model" Model System To Study Neurodegeneration Mol. Interv., October 1, 2005; 5(5): 292 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Seki, N. Adachi, Y. Ono, H. Mochizuki, K. Hiramoto, T. Amano, H. Matsubayashi, M. Matsumoto, H. Kawakami, N. Saito, et al. Mutant Protein Kinase C{gamma} Found in Spinocerebellar Ataxia Type 14 Is Susceptible to Aggregation and Causes Cell Death J. Biol. Chem., August 12, 2005; 280(32): 29096 - 29106. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shin, J. Klucken, C. Patterson, B. T. Hyman, and P. J. McLean The Co-chaperone Carboxyl Terminus of Hsp70-interacting Protein (CHIP) Mediates {alpha}-Synuclein Degradation Decisions between Proteasomal and Lysosomal Pathways J. Biol. Chem., June 24, 2005; 280(25): 23727 - 23734. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Dedmon, J. Christodoulou, M. R. Wilson, and C. M. Dobson Heat Shock Protein 70 Inhibits {alpha}-Synuclein Fibril Formation via Preferential Binding to Prefibrillar Species J. Biol. Chem., April 15, 2005; 280(15): 14733 - 14740. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Auluck, M. C. Meulener, and N. M. Bonini Mechanisms of Suppression of {alpha}-Synuclein Neurotoxicity by Geldanamycin in Drosophila J. Biol. Chem., January 28, 2005; 280(4): 2873 - 2878. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |